Search results
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 4 days agoPfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn...
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
CNBC· 3 hours agoLeading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France...
Amazon, Morgan Stanley, Pfizer to Announce French Investments
Bloomberg via Yahoo Finance· 3 hours ago(Bloomberg) -- Amazon.com Inc., Pfizer Inc. and Morgan Stanley are among the companies poised to...
France secures jobs, investments from Amazon, Pfizer and Morgan Stanley
Reuters· 2 hours agoMacron wants to burnish Paris' role as a top European business capital as the French economy faces a...
Pfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen Next
Simply Wall St. via Yahoo Finance· 1 day agoPfizer Inc. (NYSE:PFE) just released its first-quarter report and things are looking bullish. It was...
Pfizer announces 500 million euros investment in France
Reuters via Yahoo Finance· 8 hours agoPARIS, May 12 (Reuters) - U.S. pharmaceutical and healthcare giant Pfizer announced on Sunday a 500 million-euro ($538 million) investment in France for research and development ...
Pfizer Agrees to Settle More Than 10,000 Zantac Cancer Lawsuits
Insurance Journal· 4 days agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever | The Motley Fool
The Motley Fool· 4 days agoHere is why Johnson & Johnson (JNJ -0.21%), Abbott Labs (ABT 0.04%), and Pfizer (PFE -0.55%) should...
Pfizer Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 4 days agoPfizer Inc (NYSE:PFE) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-09. As investors...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoStrengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent...